# Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan

> **NCT06443307** · — · RECRUITING · sponsor: **Peking University** · enrollment: 933 (estimated)

## Conditions studied

- Colorectal Cancer
- Solid Tumor

## Interventions

- **DRUG:** Irinotecan Liposome

## Key facts

- **NCT ID:** NCT06443307
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 933 (ESTIMATED)
- **Last updated:** 2024-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06443307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06443307, "Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06443307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*